# Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

> **NCT02380274** · — · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 1030 (actual)

## Conditions studied

- Prostate Cancer
- Castration-resistant Prostate Cancer
- Metastatic Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02380274
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-27
- **Primary completion:** 2021-01-14
- **Final completion:** 2021-01-14
- **Target enrollment:** 1030 (ACTUAL)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380274, "Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02380274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*